TITLE

Treatment of Occult Hepatitis C Virus Infection: Does It Need Special Attention?

AUTHOR(S)
Rezaee-Zavareh, Mohammad Saeid; Einollahi, Behzad
PUB. DATE
July 2014
SOURCE
Hepatitis Monthly;Jul2014, Vol. 14 Issue 7, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter to the Editor
ABSTRACT
A letter to the editor is presented in response of the article "Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013" by N. Ebrahimi Daryani, S. M. Alavian and colleagues, published in 2013 issue.
ACCESSION #
97192871

 

Related Articles

  • Treating Hepatitis C in Patients with Renal Failure. Lens, Sabela; Rodriguez-Tajes, Sergio; Llovet, Laura-Patricia; Maduell, Francisco; LondoƱo, Maria-Carlota // Digestive Diseases;May2017, Vol. 35 Issue 4, p339 

    Background: There is a strong relationship between hepatitis C virus (HCV) infection and the kidney. Approximately 10-16% of the patients with HCV infection develop renal disease, and the prevalence of HCV infection in patients with renal dysfunction is higher than that of the general population...

  • The Comparision of Hepatitis C Virus (HCV) Core Antigen and HCV RNA Levels for Diagnosis of HCV Infection in Haemodialysis Patients. Kizilates, Filiz; Cekin, Yesim; Sari, Funda; Sarikaya, Metin; Seyman, Derya; Oztoprak, Nefise; Cetinkaya, Ramazan // HealthMed;2013, Vol. 7 Issue 8, p2395 

    The diagnosis and monitoring of HCV infection are commonly based on anti-HCV assays. But anti-HCV assays indicate only the exposure of virus therefore confirmation with nucleic acid amplification assays is supposed. Architect HCV Ag assay is recently developed for detecting HCV nucleocapsid...

  • Prevalence of Hepatitis C Virus Infection in Different Population Groups in Southern Italy. Montella, M.; Crispo, A.; Grimaldi, M.; Angeletti, C.; Amore, A.; Ronga, D.; Sabbatici, M.; Pisani, A.; Spiteri, D.; Serraino, D. // Infection;Feb2005, Vol. 33 Issue 1, p9 

    Background: A cross-sectional. investigation was carried out between 2000 and 2002 to assess the prevalence of hepatitis C virus infection (HCV) in Naples, southern Italy. Patients and Methods: Five groups of individuals were investigated, two at low risk and three at high risk for HCV...

  • AlphaIFN Clearance Reduced in HD Patients.  // Kidney;Jul/Aug99, Vol. 8 Issue 4, p173 

    Studies the pharmacokinetics of alpha-interferon-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function. Mean maximum serum alpha-interferon concentration; Quantification of the impact of renal failure on alpha-interferon pharmacokinetics.

  • Pegylated Interferon With or Without Ribavirin for Patients With Hepatitis C Receiving Hemodialysis.  // Annals of Internal Medicine;12/3/2013, Vol. 159 Issue 11, pI-14 

    The article reports on a study to examine the efficacy of ribavirin to pegylated interferon-alpha2a therapy in case of patients with hepatitis C virus genotype 1 receiving hemodialysis. The study was carried on patients with chronic hepatitis C who were receiving hemodialysis for end-stage renal...

  • Recent Progress in the Development of Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase. Koch, Uwe; Narjes, Frank // Current Topics in Medicinal Chemistry;Jul2007, Vol. 7 Issue 13, p1302 

    The global prevalence of hepatitis C virus (HCV) infection and the serious consequences associated with the chronic state of the disease have become a worldwide health problem. A combination therapy comprising Interferon-alpha and Ribavirin represents the current standard treatment for chronic...

  • Utility of routine real time quantitative PCR monitoring of HCV infection in haemodialysis patients. Datta, S.; Goel, N.; Wattal, C. // Indian Journal of Medical Microbiology;2015 Supplement 1, Vol. 33, pS106 

    Background: Hepatitis C virus (HCV) infection causes significant morbidity and mortality in patients of end stage renal disease (ESRD) on haemodialysis (HD). Stringent screening methods can help in its early diagnosis. Objective: The study addresses the utility of real-time quantitative...

  • Next Generation Sequencing-Based Investigation of Potential Patient-to-Patient Hepatitis C Virus Transmission during Hemodialytic Treatment. Zhao, Qi; Wen, Yujie; Jiang, Yan; Zhang, Chen; Li, Yang; Zhang, Guiyun; Zhang, Lei; Qiu, Maofeng // PLoS ONE;1/25/2016, Vol. 11 Issue 1, p1 

    We investigated potential patient-to-patient transmission of hepatitis C virus (HCV) in two hemodialysis centers in Beijing, China. Approximately 8.25% (32/388) hemodialysis patients were HCV antibody positive, and 4.90% (19/388) were HCV RNA-positive, which consisted of 2a genotype (1/19) and...

  • Anti-Viral Therapies for Hepatitis C Virus Infection: Current Options and Evolving Candidate Drugs. Fanning, Liam J. // Letters in Drug Design & Discovery;Mar2005, Vol. 2 Issue 2, p150 

    Chronic hepatitis C is a ubiquitous disease, affecting approximately 170 million globally. The hepatitis C virus (HCV) is spread by parenteral transmission of body fluids, primarily blood or blood products. The hepatitis C viral genome is a positive-sense, single-stranded RNA molecule...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics